Scott Rocklage, PhD has been with 5AM Ventures since 2003. He became a Managing Partner in 2004 after a year of being with the company. Dr. Rocklage has over thirty years of management experience with healthcare services and leadership responsibilities. He has been responsible for releasing three U.S. Drug Applications that have been approved by the FDA.
Those drugs are Omniscan, Teslascan and Cubicin. Dr. Rocklage also has experience as the Chairman and CEO of Cubist Pharmaceuticals. He served as the President and CEO of Nycomed Salutar and has also been involved in several R&D positions. Dr. Rocklage is currently serving as the Board Chairman of Rnnovia, Kinestral and Cidara.
He has his bachelor’s degree in Chemistry from the University of California and received his PhD in Chemistry from the Massachusetts Institute of Technology. While attending the Institute of Technology, he had the pleasure of working in the laboratory that Richard R. Schrock worked in for many years. He is the Nobel Prize winner in Chemistry in 2005. Read more: Scott Racklage | Bloomberg and Scott Racklage | Crunchbase
The business, 5AM Ventures, is based around early stages of life sciences. Dr. Rocklage admits that he generally does not have a typical day in the office. He is never quite sure what he will be doing each day, which makes the job even more exciting.
Some days he is working with the portfolio companies, and other days he is prompted to study new areas of life. There is never a dull day at 5AM Ventures for Dr. Rocklage. He is excited to have the opportunity to work with talented entrepreneurs that are either scientists, physicians or business executives.
He helps them shape their business ideas into potential medications that will help treat medical needs. Something that has always excited Dr. Rocklage is the ability to have immense growth tracking specific mutations or genotypes that can help treat cancer in non-traditional ways.
Dr. Scott Rocklage works hard to maintain his business and bring the best possible solutions to medications and unmet medical needs. He always stays focused and relevant to what he is working on by targeting organization and prioritizing his duties as a physician and medical director.